News Releases

RAHWAY, N.J., June 12, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the NOBIVAC® L6 and NOBIVAC® […]

Read more

If Approved, NUMELVI Will Be the First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Treatment of Pruritus Associated with Allergic Dermatitis Including Atopic Dermatitis and Treatment of Clinical Manifestations of Atopic Dermatitis in Dogs RAHWAY, N.J., June 12, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States […]

Read more

RAHWAY, N.J., Jan. 30, 2025 – Merck Animal Health, known as MSD Animal Health outside  of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that Laurie Hueneke Martens, associate vice president, Global Public Policy and Government Relations, was awarded the 8th Annual Feather in Her […]

Read more

If approved by the European Commission, the vaccine will become an available tool for governments to consider as part of a holistic strategy to combat the spread of highly pathogenic avian influenza (HPAI) which may include additional vaccinations plus enhanced biosecurity and surveillance  Potentially the first centrally registered vaccine in the European Union against the […]

Read more

Rahway, NJ, January  24, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the poultry industry as well as offer future talent development opportunities […]

Read more